IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Translational Lung Cancer Research

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

3.53

h-Index

2023-2024

 62

Rank

2023-2024

 2797

SJR

2023-2024

 1.318

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Translational Lung Cancer Research
Abbreviation Transl. Lung Cancer Res.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q1)
h-index 62
Overall Rank/Ranking 2797
SCImago Journal Rank (SJR) 1.318
Impact Score 3.53
Publisher AME Publishing Company
Country Hong Kong
ISSN 22264477, 22186751
Best Quartile Q1
Coverage History 2012-2023




About Translational Lung Cancer Research


Translational Lung Cancer Research is a journal covering the technologies/fields/categories related to Oncology (Q1). It is published by AME Publishing Company. The overall rank of Translational Lung Cancer Research is 2797. According to SCImago Journal Rank (SJR), this journal is ranked 1.318. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 62. The best quartile for this journal is Q1.

The ISSN of Translational Lung Cancer Research journal is 22264477, 22186751. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Translational Lung Cancer Research is cited by a total of 3166 articles during the last 3 years (Preceding 2023).


Translational Lung Cancer Research Impact IF 2023-2024


The Impact IF 2023 of Translational Lung Cancer Research is 3.53, which is computed in 2024 as per its definition. Translational Lung Cancer Research IF is increased by a factor of 0.11 and approximate percentage change is 3.22% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Translational Lung Cancer Research Impact IF 2024 Prediction


Impact IF 2023 of Translational Lung Cancer Research is 3.53. If the same upward trend persists, Impact IF may rise in 2024 as well.


Impact IF Trend


Year wise Impact IF of Translational Lung Cancer Research. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 3.53
2022 3.42
2021 3.43
2020 3.20
2019 2.53
2018 3.10
2017 4.37
2016 4.13
2015 1.30
2014 0.46

Translational Lung Cancer Research h-index


  Table Setting

Translational Lung Cancer Research has an h-index of 62. It means 62 articles of this journal have more than 62 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Translational Lung Cancer Research ISSN


The ISSN of Translational Lung Cancer Research is 22264477, 22186751. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Translational Lung Cancer Research Rank and SCImago Journal Rank (SJR)


The overall rank of Translational Lung Cancer Research is 2797. According to SCImago Journal Rank (SJR), this journal is ranked 1.318. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Translational Lung Cancer Research by Year


Year SJR
2023/2024 Coming Soon
2023 1.318
2022 1.056
2021 1.067
2020 1.474
2019 1.488
2018 1.669
2017 1.905
2016 1.227
2015 0.581
2014 0.239

Ranking of Translational Lung Cancer Research by Year


Year Ranking
2023/2024 Coming Soon
2023 2797
2022 3858
2021 3698
2020 2342
2019 2260
2018 1881
2017 1500
2016 3246
2015 8130
2014 15289

Translational Lung Cancer Research Publisher


Table Setting

Translational Lung Cancer Research is published by AME Publishing Company. It's publishing house is located in Hong Kong. Coverage history of this journal is as following: 2012-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Translational Lung Cancer Research is Transl. Lung Cancer Res.. This abbreviation ('Transl. Lung Cancer Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Translational Lung Cancer Research


If your research field is/are related to Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Translational Lung Cancer Research?

Translational Lung Cancer Research latest impact IF is 3.53. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.37 (2017) and 0.46 (2014), respectively, in the last 10 years. Moreover, its average IS is 2.95 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Translational Lung Cancer Research?

The Translational Lung Cancer Research has an SJR (SCImago Journal Rank) of 1.318, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.905 in 2017 and the lowest being 0.239 in 2014. Furthermore, the average SJR of the Translational Lung Cancer Research over the previous 10-year period stands at 2.95.


What's the latest h-index of the Translational Lung Cancer Research?

The latest h-index of the Translational Lung Cancer Research is 62.


Who's the publisher of the Translational Lung Cancer Research?

The Translational Lung Cancer Research is published by the AME Publishing Company, with its country of publication being the Hong Kong.


What's the current ranking of the Translational Lung Cancer Research?

The Translational Lung Cancer Research is currently ranked 2797 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1500 in 2017 and its lowest position of 15289 in 2014.


What's the abbreviation or short name for the Translational Lung Cancer Research?

The standard ISO4 abbreviation for the Translational Lung Cancer Research is Transl. Lung Cancer Res..


Is the "Translational Lung Cancer Research" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Translational Lung Cancer Research is classified as a journal that the AME Publishing Company publishes.


What's the scope or major areas of the Translational Lung Cancer Research?

The Translational Lung Cancer Research encompasses the following areas:

  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Translational Lung Cancer Research?

The Translational Lung Cancer Research is assigned the following International Standard Serial Numbers (ISSN): 22264477, 22186751.


What's the best quartile of the Translational Lung Cancer Research?

The best quartile for the Translational Lung Cancer Research is Q1 (2023).


What's the coverage history of the Translational Lung Cancer Research?

The Translational Lung Cancer Research coverage history can be summarized as follows: 2012-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 5619 Maney Publishing 45 1.64
Materials Research journal 15375 Universidade Federal de Sao Carlos 71 1.46
British Journal of Special Education journal 16076 Wiley-Blackwell Publishing Ltd 44 0.78
European Journal of Education journal 4662 Wiley-Blackwell Publishing Ltd 59 3.64
Korean Journal of Applied Microbiology and Biotechnology journal 22033 Korean Society for Applied Microbiology 0 0.00
Built Environment journal 12809 Alexandrine Press 46 1.18
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Physics and Chemistry of the Earth journal 12927 Pergamon Press Ltd. 33 0.00
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00
Cuadernos de historia (Santiago, Chile) journal 19650 Universidad de Chile 5 0.17

Check complete list




Year wise Impact Score (IS) of Translational Lung Cancer Research

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 3.53
2022 3.42
2021 3.43
2020 3.20
2019 2.53
2018 3.10
2017 4.37
2016 4.13
2015 1.30
2014 0.46



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Journal of Thoracic Oncology
Elsevier Inc. | United States

See All